文献速递外周动脉疾病

外周动脉疾病患者的抑郁:诊断不足且死亡率增加

Depression in Patients with Peripheral Artery Disease: An Underdiagnosis with Increased Mortality.
PubMed 文献 · Ann Vasc Surg · 2023-03-21

该分析包含两项研究:研究1对104例外周动脉疾病(PAD)患者行PHQ-9筛查,37%评分≥5提示至少轻度抑郁,仅18%有抑郁病史记录;研究2对148例血运重建患者行老年抑郁量表简表筛查,抑郁患病率28.4%,仅3.3%有抑郁病史记录,抑郁患者6个月内全因死亡风险更高(比值比1.48,95%CI 1.08-2.29)。

要点

  • PAD患者中抑郁筛查阳性率(37%)远高于病历记录的抑郁病史(18%)。
  • 血运重建患者中抑郁筛查患病率28.4%,仅3.3%有抑郁病史记录。
  • 抑郁患者血运重建后6个月内死亡风险更高(比值比1.48,95%CI 1.08-2.29)。

核心结论

  • 抑郁在PAD患者中诊断不足且治疗不足,并与血运重建后6个月内死亡风险增加相关(比值比1.48,95%CI 1.08-2.29)。
  • 作者认为迫切需要更完善的筛查和全面的心理健康治疗用于合并抑郁的PAD患者。

研究设计与样本

  • 研究1:2022年6月至8月,对美国北卡罗来纳大学教堂山分校血管、伤口和足病门诊所有寻求PAD相关医疗、伤口/足病或血管介入/手术治疗的患者行PHQ-9问卷筛查。
  • 研究2:2015年7月至2016年10月,对接受血运重建的成年PAD患者行老年抑郁量表简表筛查,主要结局为6个月全因死亡率。

主要发现

  • 研究1:104例PAD患者(平均年龄66.6±11.3岁,37%女性),37%的应答者PHQ-9评分≥5提示至少轻度抑郁,仅18%有抑郁病史,两者差异显著。
  • 研究1:有抑郁病史者中74%目前有抗抑郁药处方,但57%仍有PHQ-9评分升高提示可能治疗不足。
  • 研究1:男性和女性抑郁均诊断不足,但男性更易存在未识别的抑郁(卡方统计量=35.117,df=1,P<0.001)。
  • 研究2:148例患者(平均年龄70.3±11.0岁,39%女性),抑郁筛查患病率28.4%,仅3.3%有抑郁病史记录。
  • 研究2:抑郁患者血运重建后6个月内死亡比例更高(9.5% vs 0.9%;比值比1.48,95%CI 1.08-2.29)。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Among patients with peripheral artery disease (PAD), depression is diagnosed in 17-25% and negatively impacts wound healing, quality of life, and survival. We hypothesized that depression is underdiagnosed in patients with PAD. Additionally, given the associations between depression and mortality in PAD patients, there is an increased need to investigate the strength of this relationship. The present analysis includes 2 studies to address the following aims: (1) Investigation of the prevalence of concomitant PAD and depression in a cohort from the Southeastern United States, and (2) Examination of the association between depression and all-cause mortality in a cohort of Canadian patients with PAD. METHODS: STUDY 1: From June-August 2022, the Patient Health Questionnaire Module 9 (PHQ-9) was administered to all patients seeking PAD-related care including medical, wound/podiatric, or vascular interventional/surgical treatment, in the University of North Carolina-Chapel Hill Vascular, Wound, and Podiatry clinics. The PHQ-9 assesses symptoms over 2 weeks and is scored 0-27, with higher scores indicating increasingly severe depression. Demographics, primary diagnosis, depression history, and antidepressant prescription were determined through chart review. We compared the proportion of positive depression screenings (PHQ-9 ≥ 5) to known depression. Among those treated for depression, the PHQ-9 score severity was evaluated. T-tests and χ2 tests were used to compare means and proportions. STUDY 2: From July 2015 to October 2016, the Geriatric Depression Scale Short Form was administered to adult patients with PAD undergoing revascularization. The Geriatric Depression Scale Short Form is a self-report measure of depression with a score >5 consistent with depression. The prevalence of depression was determined; primary outcome was all-cause mortality at 6 months. RESULTS: STUDY 1: In 104 PAD patients (mean age 66.6 ± 11.3 years, 37% female), 37% of respondents scored ≥5 on the PHQ-9 survey, indicating at least mild depression. Only 18% of PAD patients had a history of depression, demonstrating a significant difference between the PHQ-9 findings and documented medical history. While depression was underdiagnosed in both men and women, men were more likely to have unrecognized depression (chi-squared statistic = 35.117, df = 1, P < 0.001). Among those with a history of depression, 74% had a current prescription for antidepressant medication, but 57% still had an elevated PHQ-9 score indicating possible undertreatment. STUDY 2: In 148 patients (mean age 70.3 ± 11.0 years, 39% female) the prevalence of screened depression was 28.4%, but only 3.3% had a documented history of depression suggesting significant underdiagnosis. Patients with depression were significantly more likely to die within 6 months of revascularization (9.5% vs. 0.9%; odds ratio 1.48, 95% confidence interval: 1.08 to 2.29). There was no association between depression and risk of length of stay, reintervention, or readmission. CONCLUSIONS: Depression is underdiagnosed and undertreated among patients with PAD, which has grave consequences as it is associated with 1.5 times the odds of mortality within 6 months of revascularization. There is a critical need for more robust screenings and comprehensive mental health treatment for patients with concomitant depression and PAD.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Welch KG, Faria I, Browder SE, et al. Depression in Patients with Peripheral Artery Disease: An Underdiagnosis with Increased Mortality. Ann Vasc Surg. 2023. PMID: 36948397. doi:10.1016/j.avsg.2023.03.002

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。